---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-027037"
form_type: "8-K"
ticker: "IDXG"
cik: "0001054102"
company_name: "INTERPACE BIOSCIENCES, INC."
filed_at: "2021-11-03T23:59:59+00:00"
generated_at: "2026-06-28T13:39:32.692262+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Interpace enters $8M term loan with BroadOak at 9% to repay private equity loans

## Summary
- $8M term loan from BroadOak at 9% interest, matures Oct 2024 or change-of-control.
- Proceeds used to repay $4.5M Ampersand and $3M 1315 Capital promissory notes plus interest.
- Loan includes 3% origination fee and terminal payment of 15%-30% of original principal.
- Subordinate to Comerica's $7.5M revolving facility; secured by substantially all assets.
- Company believes new debt improves liquidity and operating flexibility without dilution.

## SEC filing metadata
- accession: 0001493152-21-027037
- form_type: 8-K
- ticker: IDXG
- cik: 0001054102
- company_name: INTERPACE BIOSCIENCES, INC.
- filed_at: 2021-11-03T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1054102/000149315221027037/0001493152-21-027037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1054102/000149315221027037/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-027037
- JSON: https://secwatch.observer/filing/0001493152-21-027037.json
- Plain text: https://secwatch.observer/filing/0001493152-21-027037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.